BALAXI PHARMACEUTICALS Ltd (BALAXI)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 46.00
% Change: -2.21% (Prev Close: 47.04)

Volume: 1,02,195
% Change: 63.18% (Prev Volume: 62,626)

Delivery: 63,702
Delivery % : 62.33
% Change: 210.23% (Prev Delivery: 20,534)

Turnover: 48 Lacs
% Change: 62.04% (Prev Turnover: 29)

💹 EOD Valuation

P/E Ratio: 13.45
P/B Ratio: 1.10
Market Cap: 254 Rs. Cr.


Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: BALAXI
Market Cap: 253 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 127.45
52 Week Low: 42.56

All-Time High: 216.04 Rs.
All-Time Low: 2.30 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.29% | -11.22% | -34.98% | -57.12% | -28.37%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 65.99%

Change (3Y | 1Y): -6.87% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 8.87%

Change (3Y | 1Y): 8.87% | -7.15%

DII Holding

DII Holding: 0.02%

Change (3Y | 1Y): -19.01% | 0.00%

Public Holding: 25.12%


🏦 Financial Strength

Debt to Equity: 0.23
Debt: 53.43 Rs. Cr.

Book Value: 41.97 Rs.
Current Ratio: 4.45
Interest Coverage: 7.20
Free Cash Flow: -56.76 Rs. Cr.


📈 Growth & Sales

Sales Growth: 23.54%

Sales Growth Qtr (YOY | QoQ):
7.80% | -7.25%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
45.01% | 1.55% | 23.54%


💰 Profit & Earnings

Profit Growth %

Profit Growth: -49.84%

Profit Growth Qtr (YOY | QoQ):
-95.52% | -96.64%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
32.75% | -19.19% | -49.84%


EPS Rs.

EPS (TTM): 3.42 Rs.

EPS Qtr (Last Year | Latest):
1.17 Rs. | 0.05 Rs.

EPS Annual (Last Annual | Annual March):
-0.44 Rs. | 4.54 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
30.15% | -21.82%


Net Profit Rs. Cr.

Net Profit (TTM): 18.88 Rs. Cr.

Net Profit (Annual - March): 25.07 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
6.48| 8.64 | 0.29


EBITDA Rs. Cr.

EBITDA (Quarter): 2.38 Rs. Cr.
EBITDA (Previous Yr Ql): 8.24 Rs. Cr.

EBITDA (Annual - March): 34.66 Rs. Cr.
EBITDA (Previous Annual): 45.24 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
31.39% | -14.67%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 10.51%

OPM Qtr (Previous | Current):
16.45% | 5.88%

OPM Annual (5 Yrs | Last Yr | March):
16.50% | 18.49% | 11.04%


Return on Equity %

ROE: 11.61%

ROE (5 Yrs | 3 Yrs | Last Yr):
15.47% | 3.82% | -25.94%


Return on Capital Employed %

ROCE: 12.95%

ROCE (5 Yrs | 3 Yrs | Last Yr):
44.62% | 23.63% | 20.69%


Return on Assets %

ROA (TTM): 8.85%

ROA (5 Yrs | 3 Yrs | Last Yr):
20.33% | 3.64% | -20.01%



PEG Ratio: -0.70
Dividend Yield: 0.00%

PE 3 Yrs: 12.63
PE 5 Yrs: 13.19

Dividend Yield: 0.00%


👥 Company

BALAXI PHARMACEUTICALS Ltd

BALAXI

Promoter Holding: %